You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fingolimod Hydrochloride

Showing 26 - 50 of 1,879
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronavirus Disease (COVID-19) Trial in Fuzhou (Fingolimod 0.5 mg)

Withdrawn
  • Coronavirus Disease (COVID-19)
  • Fingolimod 0.5 mg
  • Fuzhou, China
    Wan-Jin Chen
Nov 11, 2020

Relapsing-remitting Multiple Sclerosis Trial in Stockholm (Rituximab)

Active, not recruiting
  • Relapsing-remitting Multiple Sclerosis
  • Stockholm, Sweden
    Fredrik Piehl
Apr 8, 2022

Healthy Trial in Cairo (Sphingomod, Gilenya)

Completed
  • Healthy
  • Cairo, Egypt
    Genuine Research Center GRC
Dec 2, 2020

Relapsing Forms of Multiple Sclerosis Trial in Worldwide (Fingolimod)

Completed
Has Results
  • Relapsing Forms of Multiple Sclerosis
  • Cullman, Alabama
  • +457 more
Mar 26, 2021

Multiple Sclerosis, Relapsing-Remitting Trial in United Kingdom, United States (Early Highly Effective Therapies Group,

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Early Highly Effective Therapies Group
  • Escalation Therapies Group
  • Aurora, Colorado
  • +30 more
Jul 22, 2022

Relapsing Remitting Multiple Sclerosis Trial in Puerto Rico, United States (Fingolimod, Disease Modifying therapy)

Completed
Has Results
  • Relapsing Remitting Multiple Sclerosis
  • Cullman, Alabama
  • +122 more
Dec 9, 2020

Renal Insufficiency Trial in Moscow (fingolimod (FTY720))

Completed
  • Renal Insufficiency
  • fingolimod (FTY720)
  • Moscow, Russian Federation
    Novartis Investigator Site
Dec 6, 2020

Relapsing Multiple Sclerosis Trial in Worldwide (Ofatumumab)

Recruiting
  • Relapsing Multiple Sclerosis
  • Ofatumumab
  • Cullman, Alabama
  • +165 more
Jan 13, 2023

Diabetic Peripheral Neuropathic Pain Trial in Luoyang (HSK16149 20mg BID)

Recruiting
  • Diabetic Peripheral Neuropathic Pain
  • HSK16149 20mg BID
  • Luoyang, Henan, China
    The First Affiliated Hospital of Henan University of Science and
Nov 2, 2023

Laparoscopy, Anesthesia, Intravenous Trial in China (BT-KTM-I, Ketanest®S)

Not yet recruiting
  • Laparoscopy
  • Anesthesia, Intravenous
  • Guangzhou, Guangdong, China
  • +11 more
Oct 15, 2023

Multiple Sclerosis COVID-19/Vaccination Treated With Ofatumumab

Completed
  • Multiple Sclerosis
    • East Hanover, New Jersey
      Novartis
    Jul 14, 2023

    Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)

    Active, not recruiting
    • Adult Solid Neoplasm
    • Erlotinib Hydrochloride
    • Irinotecan Hydrochloride
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 12, 2023

    Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)

    Not yet recruiting
    • Breast Cancer
    • Beijing, Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Dec 1, 2023

    Pain, Insomnia Trial in Guangzhou (Compound ibuprofen polyrelease tablets, reference 1 (R1): Ibuprofen Tablets (Motrin

    Not yet recruiting
    • Pain
    • Insomnia
    • Compound ibuprofen polyrelease tablets
    • reference 1 (R1): Ibuprofen Tablets (Motrin IB®)reference 2 (R2): Diphenhydramine Hydrochloride Tablets (Benadryl®)
    • Guangzhou, Guangdong, China
      Zhujiang Hospital of Southern Medical University
    Feb 6, 2023

    Multiple Sclerosis (MS) Registries

    Active, not recruiting
    • Progressive Multifocal Leukoencephalopathy
    • Tysabri
    • Cambridge, Massachusetts
      Research Site
    Mar 21, 2022

    Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Propranolol
    • Propranolol hydrochloride
    • +2 more
    • (no location specified)
    Jul 31, 2023

    Platinum-resistant Ovarian Cancer Trial in Shanghai (Oral Topotecan Combined With Anlotinib)

    Not yet recruiting
    • Platinum-resistant Ovarian Cancer
    • Oral Topotecan Combined With Anlotinib
    • Shanghai, China
      Xinhua Hospital Affiliated to Shanghai Jiaotong University Schoo
    Feb 12, 2023

    Multiple Sclerosis Trial in Clermont-Ferrand (Methylprednisolone, Placebo, natalizumab (NTZ))

    Recruiting
    • Multiple Sclerosis
    • Clermont-Ferrand, France
      CHU Clermont-Ferrand
    Jan 5, 2023

    Associated With Cardiomyopathy and Heart Failure After Cancer

    Recruiting
    • Hodgkin Lymphoma in Remission
    • +6 more
    • Assessment of Therapy Complications
    • +3 more
    • Birmingham, Alabama
    • +78 more
    Jan 11, 2023

    Nalbuphine Allergy, Ablation, Safety Trial in China (Nalbuphine, Morphine)

    Recruiting
    • Nalbuphine Allergy
    • +2 more
    • Hefei, Anhui, China
    • +19 more
    Dec 28, 2022

    Relapsing Remitting Multiple Sclerosis RRMS Trial in Germany, Switzerland (Fingolimod)

    Completed
    Has Results
    • Relapsing Remitting Multiple Sclerosis RRMS
    • Bochum, Germany
    • +9 more
    Feb 14, 2020

    Myelofibrosis Trial in Changsha (Jaktinib Hydrochloride Tablets)

    Not yet recruiting
    • Myelofibrosis
    • Jaktinib Hydrochloride Tablets
    • Changsha, Hunan, China
      The Third Hospital of Changsha
    Nov 9, 2023

    Natural Killer Cells in Multiple Sclerosis Patients Treated With

    Terminated
    • Relapsing-Remitting Multiple Sclerosis
      • Berlin, Germany
        Charité Universitätsmedizin Berlin
      Jul 28, 2021

      Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in

      Active, not recruiting
      • Pancreatic Acinar Cell Carcinoma
      • +8 more
      • 3-Dimensional Conformal Radiation Therapy
      • +8 more
      • Mobile, Alabama
      • +697 more
      Nov 16, 2022

      Nausea and Vomiting Trial in Xi'an (Palonosetron HCl capsules)

      Recruiting
      • Nausea and Vomiting
      • Palonosetron hydrochloride capsules
      • Xi'an, Shaanxi, China
        The First Affiliated Hospital, the Air Force Medical University
      Jan 18, 2023